Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Topiroxostat

An inhibitor of xanthine oxidoreductase, the enzyme that produces uric acid, approved in Japan in 2013 for the treatment of gout and hyperuricaemia. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?It is a 'hybrid' inhibitor: first it occupies the enzyme's active site, then it forms a covalent bond with the molybdenum atom at its centre, blocking it for a long time.

TopiroxostatGo to the active ingredient →
TopiroxostatActive ingredientTopiroxostatCat. No. P-T163-001CAS 577778-58-6

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.